SAGE Sage Therapeutic

USD 10.75 0.00 0
Icon

Sage Therapeutic (SAGE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 10.75

0.00 (0.00)%

USD 0.68B

1.18M

USD 20.89(+94.35%)

USD 47.29 (+339.91%)

Icon

SAGE

Sage Therapeutic (USD)
COMMON STOCK | NSD
USD 10.75
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.68B

USD 47.29 (+339.91%)

USD 10.75

Sage Therapeutic (SAGE) Stock Forecast

Show ratings and price targets of :
USD 20.89
(+94.35%)

Based on the Sage Therapeutic stock forecast from 16 analysts, the average analyst target price for Sage Therapeutic is USD 20.89 over the next 12 months. Sage Therapeutic’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Sage Therapeutic is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Sage Therapeutic’s stock price was USD 10.75. Sage Therapeutic’s stock price has changed by -0.92% over the past week, -8.12% over the past month and -80.54% over the last year.

No recent analyst target price found for Sage Therapeutic
No recent average analyst rating found for Sage Therapeutic

Company Overview Sage Therapeutic

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO, a CIV injection for the treatment of postpartum depression (PPD) in adults; and ZURZUVAE, a neuroactive steroid, a positive allosteri...Read More

https://www.sagerx.com

215 First Street, Cambridge, MA, United States, 02142

487

December

USD

USA

Adjusted Closing Price for Sage Therapeutic (SAGE)

Loading...

Unadjusted Closing Price for Sage Therapeutic (SAGE)

Loading...

Share Trading Volume for Sage Therapeutic Shares

Loading...

Compare Performance of Sage Therapeutic Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SAGE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Sage Therapeutic (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD122.24B 30.78 20.00

ETFs Containing SAGE

Symbol Name SAGE's Weight Expense Ratio Price(Change) Market Cap
PSIL
AdvisorShares Psychedelic.. 2.87 % 0.99 % 0.00 (0.00%) USD5.92M

Frequently Asked Questions About Sage Therapeutic (SAGE) Stock

Based on ratings from 16 analysts Sage Therapeutic's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 8 buy, 2 sell and 18 hold ratings.

Unfortunately we do not have enough data on SAGE's stock to indicate if its a good dividend stock.

Based on targets from 16 analysts, the average taret price for SAGE is USD 20.89 over the next 12 months. The maximum analyst target price is USD 34 while the minimum anlayst target price is USD 8.

SAGE stock's Price/Earning ratio is 3.09. Our analysis grades SAGE stock's Price / Earning ratio at F. This means that SAGE stock's Price/Earning ratio is above 41% of the stocks in the Biotechnology sector in the NSD exchange. Based on this SAGE may be fairly valued for its sector

The last closing price of SAGE's stock was USD 10.75.

The most recent market capitalization for SAGE is USD 0.68B.

Based on targets from 16 analysts, the average taret price for SAGE is projected at USD 20.89 over the next 12 months. This means that SAGE's stock price may go up by +94.35% over the next 12 months.

Following are ETFs with the highest allocation to Sage Therapeutic's stock :

PSIL

As per our most recent records Sage Therapeutic has 487 Employees.

Sage Therapeutic's registered address is 215 First Street, Cambridge, MA, United States, 02142. You can get more information about it from Sage Therapeutic's website at https://www.sagerx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...